Goldman Sachs
MJN

Goldman Sachs’s Mead Johnson Nutrition Company MJN Stock Holding History

Goldman Sachs’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,695,000
Closed -$151M – 7145
2017
Q1 		$151M Buy
+1,695,000
New +$139M 0.04% 498
2016
Q2 		– Sell
-53,500
Closed -$4.55M – 7442
2016
Q1 		$4.55M Hold
53,500
– – ﹤0.01% 2795
2015
Q4 		$4.22M Buy
+53,500
New +$4.21M ﹤0.01% 2984
2015
Q1 		– Sell
-663,000
Closed -$66.7M – 7439
2014
Q4 		$66.7M Sell
663,000
-21,000
-3% -$2.09M 0.02% 903
2014
Q3 		$65.8M Buy
684,000
+328,900
+93% +$31.2M 0.02% 884
2014
Q2 		$33.1M Buy
355,100
+55,100
+18% +$4.82M 0.01% 1403
2014
Q1 		$24.9M Sell
300,000
-570,400
-66% -$46.2M 0.01% 1587
2013
Q4 		$72.9M Sell
870,400
-161,400
-16% -$13.1M 0.02% 797
2013
Q3 		$76.6M Buy
1,031,800
+559,700
+119% +$42M 0.03% 707
2013
Q2 		$37.4M Buy
+472,100
New +$37.9M 0.01% 1079

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Goldman Sachs's MJN Position: Q2 2017 in Review

Goldman Sachs sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 3,696,172 shares — an estimated $329M sold.

Goldman Sachs first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $530M in Q4 2015. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Goldman Sachs reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Goldman Sachs sold 3,696,172 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $329M.
  • Goldman Sachs first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Goldman Sachs's Mead Johnson Nutrition Company position peaked at $530M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Goldman Sachs's 13F filing for Q2 2017, filed 14 Aug 2017.